106 related articles for article (PubMed ID: 4593264)
1. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Eule H; Kärnbach E; Kaluza P; Herrmann H
Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
[No Abstract] [Full Text] [Related]
2. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Herrmann H; Eule H
Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
[No Abstract] [Full Text] [Related]
3. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
4. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
5. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Guerra Sanz FJ
Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
[No Abstract] [Full Text] [Related]
6. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
7. [Preliminary results of a therapeutic trial concerning the administration of isoniazid + rifampicin once a week, immediately or after an initial period of continuous treatment].
Eule H
Bull Int Union Tuberc; 1973 Jun; 48(0):117-24. PubMed ID: 4602466
[No Abstract] [Full Text] [Related]
8. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
9. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
10. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
11. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
13. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
14. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
[No Abstract] [Full Text] [Related]
15. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
Anastasatu C; Bungeteanu G; Sibila S
Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
[No Abstract] [Full Text] [Related]
16. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
17. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
[No Abstract] [Full Text] [Related]
18. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
19. [Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)].
Fraga H; Gomes O; Paz de Almeida A; Gerhardt G; Santiago AC
Bull Int Union Tuberc; 1973 Jun; 48(0):125-38. PubMed ID: 4602467
[No Abstract] [Full Text] [Related]
20. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
Gomi J; Aoyagi T
Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
